Mangalam Drugs & Organics Ltd (MANGALAM) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Mangalam Drugs & Organics Ltd reported sales of ₹57.12 Cr, operating profit of ₹0.91 Cr (OPM 1.59%) and net profit of ₹-7.64 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.
MANGALAM quarterly results (₹ Cr) Metric Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sales 79.94 88.71 72.78 57.21 49.54 58.38 67.29 57.12 Expenses 71.24 79.94 62.88 61.83 52.38 59.92 72.91 56.21 Operating Profit 8.7 8.77 9.9 -4.62 -2.84 -1.54 -5.62 0.91 OPM 10.88% 9.89% 13.6% -8.08% -5.73% -2.64% -8.35% 1.59% Other Income 0.14 0.14 0.47 0.14 0.03 0.22 0.09 0.11 Interest 3.67 3.49 4.03 4.04 5.03 4.05 3.08 3.68 Depreciation 3.97 4.05 4.7 4.48 4.63 4.46 4.66 4.09 Profit before tax 1.2 1.37 1.64 -13 -12.47 -9.83 -13.27 -6.75 Tax -124.17% 5.84% 95.73% 6.15% -41.06% 0% 1.13% 13.19% Net Profit 2.69 1.29 0.06 -13.8 -7.35 -9.84 -13.42 -7.64 EPS in Rs 1.7 0.82 0.04 -8.72 -4.64 -6.22 -8.48 -4.83
MANGALAM profit & loss, annual (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 TTM Sales 369 318 232 232 Expenses 351 282 247 241 Operating Profit 17 36 -15 -9 OPM 4.7% 11% -6% -3.9% Other Income 0 0 1 0 Interest 14 15 16 16 Depreciation 15 17 18 18 Profit before tax -11 5 -49 -42 Tax -18% -41% -9% - Net Profit -9 7 -44 -38 EPS in Rs -5.73 4.25 -28.05 -24.17 Dividend Payout 0% 0% 0% -
MANGALAM balance sheet (₹ Cr) Metric Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 16 16 16 16 Reserves 120 133 112 87 Borrowings 107 96 95 105 Other Liabilities 91 121 94 106 Total Liabilities 334 366 317 315 Fixed Assets 148 163 159 159 CWIP 8 3 4 0 Investments 0 0 0 0 Other Assets 178 201 155 156 Total Assets 334 366 317 315
MANGALAM cash flows (₹ Cr) Metric Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 4 43 4 Cash from Investing Activity -12 -19 -12 Cash from Financing Activity 5 -22 6 Net Cash Flow -3 1 -2 Free Cash Flow -8 23 -8 CFO/OP 23% 118% -30%
MANGALAM ratios Metric Mar 2024 Mar 2025 Mar 2026 Debtor Days 28 45 63 Inventory Days 185 303 239 Days Payable 99 199 177 Cash Conversion Cycle 113 149 126 Working Capital Days 11 5 -65 ROCE - 8% -14%